Mr. Epstein, the late financier and sex offender, started by putting $40 million into Valar Ventures, a firm backed by Mr. Thiel. Today that investment is worth about $170 million.
The estimate from the nonpartisan Congressional Budget Office is all but certain to inflame an already intense debate inside the G.O.P. about the fiscal consequences of their bill to enact President Trump’s agenda.
Police, customs officials and spies are reinforcing China’s embargo on the critical minerals that it overwhelmingly controls.
Drivers in the country, Europe’s largest car market, are avoiding vehicles from Tesla, which has seen a drop in sales in other countries as well.
Even the president appears to be doubting his strategy to win over Beijing, as relations fray between the trading partners.
In the rush to sign players early, some mistakes are made. But as Shai Gilgeous-Alexander reaches basketball’s biggest stage, he is taking his shoe company with him.
Movies that are major downers, it turns out, are a big film festival draw. “Sometimes the world is such that you just need to wallow a little bit.”
Easterly Government Properties is working to shift its portfolio away from its heavy reliance on the federal government — but not because of President Donald Trump.
The company, which owns 9.7M SF of properties, first told investors in early 2024 it intends to diversify its portfolio away from the federal tenants that have filled its buildings since its 2009 founding. It is looking to reduce its federal exposure from 95% to 70% of its portfolio while increasing the share of state and local government tenants to 15% and private-sector tenants to 15%.
“Today, we are aggressively looking for government-adjacent buildings that look like the…
Pharma companies in the U.S. have announced roughly $158B in new investments this year, most of which will be directed toward the development of new plants for manufacturing drugs of all kinds.
These plans have created a site selection race for municipalities and economic development teams across the country with decisions expected soon. Many see the competition to snag a new facility entering a final stage, with the winners possibly netting hundreds of jobs and significant tax revenue.
“All the major pharma companies have made some kind of commitment,” NCBiotech CEO Doug Edgeton said. “I do think there is an urgency now…
The president has ratcheted up the rate on foreign metals to 50 percent, double the previous rate, saying the levies weren’t high enough to help the U.S. industry.